121 related articles for article (PubMed ID: 6307706)
1. Phase II trial of m-AMSA in gallbladder and cholangiocarcinoma: a Southwest Oncology Group Study.
Bukowski RM; Leichman LP; Rivkin SE
Eur J Cancer Clin Oncol; 1983 Jun; 19(6):721-3. PubMed ID: 6307706
[TBL] [Abstract][Full Text] [Related]
2. Phase II trial of m-AMSA in hepatocellular carcinoma: a Southwest Oncology Group Study.
Bukowski RM; Legha S; Saiki J; Eyre HJ; O'Bryan R
Cancer Treat Rep; 1982 Aug; 66(8):1651-2. PubMed ID: 6286120
[TBL] [Abstract][Full Text] [Related]
3. Phase II study of amsacrine (m-AMSA) in advanced lymphomas: a Southwest Oncology Group study.
Weick JK; Jones SE; Ryan DH
Cancer Treat Rep; 1983 May; 67(5):489-92. PubMed ID: 6687839
[TBL] [Abstract][Full Text] [Related]
4. The treatment of melanoma with m-AMSA. A Cancer and Leukemia Group B phase II study.
Amrein PC; Poulin RF; Coleman M; Richards F; Weil M; Kennedy BJ; Carey RW; Green MR; Holland JF; Weinberg V
Am J Clin Oncol; 1984 Jun; 7(3):269-71. PubMed ID: 6547269
[TBL] [Abstract][Full Text] [Related]
5. m-AMSA in epithelial carcinoma of the ovary. A Southwest Oncology Group study.
Hilgers RD; Legha SS; Panettiere FJ; Alberts DS
Am J Clin Oncol; 1983 Jun; 6(3):277-9. PubMed ID: 6687779
[TBL] [Abstract][Full Text] [Related]
6. Phase II trial of amsacrine (AMSA) in urinary bladder cancer.
Natale RB; Yagoda A; Blumenreich MS; Watson RC
Cancer Treat Rep; 1983 Apr; 67(4):391-2. PubMed ID: 6687836
[No Abstract] [Full Text] [Related]
7. Phase II evaluation of 4'-(9-acridinylamino)-methanesulfon-m-anisidide (m-AMSA) in patients with gastric adenocarcinoma.
Sordillo PP; Magill GB; Gralla RJ; Kelsen DP
Am J Clin Oncol; 1982 Jun; 5(3):273-5. PubMed ID: 6896259
[TBL] [Abstract][Full Text] [Related]
8. Phase II trial of (m-AMSA) 4'-9-(acridinylamino)-methanesulfon-m-aniside in primary liver cancer.
Cheng E; Lightdale C; Young C; Yagoda A; Fortner J; Golbey R
Am J Clin Oncol; 1983 Apr; 6(2):211-3. PubMed ID: 6299095
[No Abstract] [Full Text] [Related]
9. Meta AMSA (m-AMSA) in patients with advanced ovarian carcinoma.
Kearsley JH; Page JP; Levi JA; Woods RL; Tattersall MH; Fox RM; Coates AS
Aust N Z J Obstet Gynaecol; 1982 May; 22(2):107-9. PubMed ID: 6958247
[No Abstract] [Full Text] [Related]
10. M-AMSA in disseminated prostatic carcinoma: a phase II study.
Drelichman A; Decker DA; Al-Sarraf M; Dhabuwala CB
Cancer Treat Rep; 1982 Nov; 66(11):1993-4. PubMed ID: 6897206
[No Abstract] [Full Text] [Related]
11. Phase II trial of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with metastatic renal cell carcinoma.
Van Echo DA; Markus S; Aisner J; Wiernik PH
Cancer Treat Rep; 1980; 64(8-9):1009-10. PubMed ID: 6893810
[No Abstract] [Full Text] [Related]
12. Treatment of advanced colorectal carcinoma with AMSA.
Ferraro JA; Horton J; Weissman C; Ruckdeschel JC; O'Donnell M; Ludlum D
Cancer Treat Rep; 1981; 65(3-4):345-7. PubMed ID: 6894563
[TBL] [Abstract][Full Text] [Related]
13. Phase II clinical trial of 4'-(9-acridinylamino) methanesulphon-m-anisidide (m-AMSA) in the treatment of advanced non-Hodgkin's lymphomas.
Abate G; Villari P; Comella P; D'Aprile M; Castello G; Silvestro P; Zarrilli D; Pergola M
Haematologica; 1985; 70(1):35-8. PubMed ID: 3924754
[No Abstract] [Full Text] [Related]
14. A phase II trial of m-AMSA in head and neck cancer.
Forastiere AA; Young CW; Wittes RE
Cancer Chemother Pharmacol; 1981; 6(2):145-6. PubMed ID: 6895486
[TBL] [Abstract][Full Text] [Related]
15. A phase II study of m-AMSA in patients with primary liver cancer.
Falkson G; Coetzer B; Klaassen DJ
Cancer Chemother Pharmacol; 1981; 6(2):127-9. PubMed ID: 6895485
[TBL] [Abstract][Full Text] [Related]
16. Phase II evaluation of amsacrine (m-AMSA) in solid tumors, myeloma, and lymphoma: a University of Arizona and Southwest Oncology Group Study.
Ahmann FR; Meyskens FL; Jones SE; Bukowski RM; Saiers JH; Ryan DH; Costanzi J; Vaughn CB; Coltman CA
Cancer Treat Rep; 1983; 67(7-8):697-700. PubMed ID: 6688199
[TBL] [Abstract][Full Text] [Related]
17. Amsacrine (m-AMSA) in squamous cell carcinoma of the uterine cervix: a Southwest Oncology Group study.
Hilgers RD; Legha SS; Boutselis JG; Hannigan EV; Stephens RL; Tranum BL; Surwit E
Cancer Treat Rep; 1984 Feb; 68(2):443-4. PubMed ID: 6546533
[No Abstract] [Full Text] [Related]
18. Phase II study of m-AMSA in advances malignant melanoma.
Arseneau JC; Wolter JM; Probert JC; Kuperminc M
Am J Clin Oncol; 1982 Aug; 5(4):433-6. PubMed ID: 6896795
[TBL] [Abstract][Full Text] [Related]
19. Phase II study of amsacrine in solid tumors: a report of the EORTC Early Clinical Trial-Group.
De Jager R; Siegenthaler P; Cavalli F; Klepp O; Bramwell V; Joss R; Alberto P; van Glabbeke M; Renard J; Rozencweig M; Hansen HH
Eur J Cancer Clin Oncol; 1983 Feb; 19(2):289-93. PubMed ID: 6687457
[TBL] [Abstract][Full Text] [Related]
20. Phase II evaluation of 4'-(9-acridinylamino)methanesulfon-m-anisidide (AMSA) in patients with non-small cell lung cancer.
Casper ES; Gralla RJ; Kelsen DP; Natale RB; Sordillo P; Houghton A
Cancer Treat Rep; 1980; 64(2-3):345-7. PubMed ID: 6893294
[No Abstract] [Full Text] [Related]
[Next] [New Search]
